MUC1 and idiopathic pulmonary fibrosis: Serum KL-6 levels are elevated in patients with CTD-ILD as well as IPF, and they correlate with the severity of CTD-ILD, as determined by HRCT and PFT, and serve as a biomarker for predicting progression [16, 30].